October 15, 2020
“Catalyst Biosciences (CBIO)… Other analysts don’t beg to differ. With 3 Buy ratings and no Holds or Sells, the word on the Street is that CBIO is a Strong Buy. At $19.33, the average price target implies 303% upside potential… Continue Reading…
June 24, 2020
“Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today announced that it has entered into a co-promotion partnership with Indegene Inc. to establish multichannel digital marketing programs throughout the United States and expand the capabilities for the engagement of health care providers (“HCPs”) who… Continue Reading…
June 11, 2020
“Wall Street analysts have assigned a consensus price target of $2.3 to the stock, which implies a rise of 414.54% to its current value. Analysts have been projecting $0.7 as a low price target for the stock while placing it… Continue Reading…
June 10, 2020
“Positions in Actinium Pharmaceuticals Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 14 institutional holders increased their position in Actinium Pharmaceuticals Inc. [AMEX:ATNM] by around 1,793,626… Continue Reading…
June 4, 2020
“3 “Strong Buy” Healthcare Stocks Under $5 With Big Upside Potential“ “Actinium Pharmaceuticals (ATNM) …Bearing this in mind, McCarthy reiterated a Buy rating and $1.50 price target. The five-star analyst’s target implies shares could soar 603% in the next year.… Continue Reading…
March 11, 2020
“Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today announced it has entered into a securities purchase agreement with certain accredited institutional investors to purchase approximately $2.2 million of its common stock… The combined purchase price for one share of common stock and each… Continue Reading…
October 25, 2019
“The company shares are trading 27.88% or 0.061 points up from last closing price of $0.217, reaching $0.2775 at last check. The ATNM share price has risen in 3 of the last 5 days and is down -14.78% over the… Continue Reading…
September 20, 2019
“Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (“Actinium”) today announced that it will present at the Sachs 19th Annual Biotech in Europe Forum for Global Partnering & Investment. The forum is being held at the Congress Center Basel in Basel, Switzerland on September 25-26, 2019.… Continue Reading…
Recent Comments